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Current eﬀorts have proven inadequate to stop the transmission of Plasmodium parasites, and hence the spread of malaria, by
Anopheles mosquitoes. Therefore, a novel arsenal of strategies for inhibiting Plasmodium infection of mosquitoes is urgently
needed. In this paper, we summarize research on two approaches to malaria control, a low-tech strategy based on parasite
inhibition by the mosquito’s natural microﬂora, and a high-tech strategy using genetic modiﬁcation of mosquitoes that renders
them resistant to infection and discuss advantages and disadvantages for both approaches.
1.Introduction
Cyclopropagative development of Plasmodium parasites in
their anopheline mosquito vectors is required for transmis-
sion between human hosts. During the ﬁrst stages of this
cycle, immediately following the ingestion of gametocytes
by the female mosquito, extracellular parasites are exposed
to a harsh environment in the mosquito midgut. Following
progression to the ookinete stage in the midgut lumen, Plas-
modiumparasitesinvadethemidgutepitheliumataround20
hoursafteringestionanddevelopoverapproximately10days
intoamatureoocyst.Mitoticdivisionleadstotheproduction
of thousands of sporozoites from a single oocyst, and these
sporozoites are released into the hemolymph, at about 10–
20 days after infected blood ingestion, depending on the
Plasmodium species. At this stage, the parasites migrate to
the salivary glands from where they can be transmitted
to another host during a subsequent blood feed. Oocyst
and sporozoite populations are severely compromised by
mosquito-mounted immune responses, but the escape of a
small proportion of parasites is suﬃcient for transmission
to persist. With the increased resistance of Plasmodium to
the current arsenal of drugs and Anopheles mosquitoes to
insecticides and the lack of an eﬃcacious malaria vaccine,
it is clear that development of novel control strategies are
crucial in order to reduce malaria transmission. Here, we
discuss diﬀerent methods to control transmission of malaria
parasites via low-tech approaches using the mosquito’s natu-
ral bacteria microﬂora or high-tech approaches involving the
direct manipulation of mosquito genomes to render them
resistant to Plasmodium.
2.TargetingPlasmodium Parasites through
Mosquito Microbiota
Numerous surveys of mosquito midgut-associated bacteria
(MAB) in laboratory and wild anopheline mosquitoes have
been performed, and common bacterial genera (Enterobac-
ter, Pseudomonas, Pantoea, and others) have been identiﬁed
[1–8], with some of these bacteria closely associated with
Anopheles mosquitoes [9–11].
A number of studies have shown that MAB impact the
ability of Plasmodium parasites to develop to the oocyst
stage in the mosquito gut tissue. Mosquitoes that have been
treated with antibiotics to remove their MAB are more
susceptible to Plasmodium infection, and reconstitution of
the bacterial ﬂora results in infections at the same level
as untreated control mosquitoes [12]. When added to a
parasite-laden blood meal, bacteria can interfere with para-
site development [1, 2, 4, 5]. Interestingly, this interference2 Journal of Tropical Medicine
appears to be exclusive to Gram-negative (G−)b a c t e r i a
but is bacterial strain dependent, suggesting some bacteria
possess an anti-Plasmodium property [1, 4]. However, no
correlation between G bacteria presence and infection status
was observed in ﬁeld populations of A. gambiae and A.
funestus from Kenya and Mali, although determination of
the timing of bacterial and/or parasite acquisition by the
mosquitoes was not performed [7].
Multiple mechanisms could result in the inhibition of
parasite infection by the presence of bacteria. Lysis of
trypanosomes [13]a n dLeishmania parasites [14]i nt r i -
atominebugshasbeenobservedfollowingbioﬁlmformation
on the parasite surface by Serratia bacteria (G−), while
no such phenomenon has been described in Plasmodium
infection of mosquitoes. Bacteria produce compounds with
potential antimalarial properties (reviewed in [14]). It was
recently identiﬁed that an Enterobacter bacterium isolated
from wild mosquitoes in Zambia produces reactive oxygen
intermediates that kill developing parasites in the midgut
lumen, inhibiting Plasmodium prior to mosquito midgut
infection [1]. Small populations of the bacterium can nearly
eliminate ookinete formation in the midgut, providing proof
of principle for the use of this and other bacteria to control
malaria parasite transmission [1]. In general, G− bacteria
show varying levels of inhibition at the early stages of
parasite development, suggesting that diverse mechanisms of
bacteria-mediated parasite inhibition exist [1].
Bacteria may play an indirect role in parasite interference
through the induction of an anti-Plasmodium immune
response in the midgut. Studies have suggested that the
mosquito’s anti-Plasmodium and antibacterial defense sys-
tems are largely overlapping. The mosquito gut microﬂora
has been shown to stimulate basal immune activity, which in
turn is acting against the malaria parasite [12, 15–17]. The
immune deﬁciency (IMD) innate immune pathway, which
is stimulated by the presence of G− bacteria and appears to
be the primary immune pathway activated in the mosquito
midgut, has been shown to control P. falciparum infec-
tion intensities through the expression of anti-Plasmodium
eﬀector molecules in multiple anopheline species [18, 19].
These molecules also control bacterial populations in the
midgut, providing a direct link between antibacterial and
anti-Plasmodium immunity [12, 15, 19].
Althoughtheabsolutemechanismofinhibitionexhibited
by most bacteria remains unclear, their potential use as a
biological-based control strategy is apparent. Nonetheless,
there are deﬁciencies in our understanding of the mosquito-
bacteria interaction that needs to be resolved before such
strategies can be implemented. A better understanding of the
acquisition of MAB by wild mosquito populations is needed.
Bacteria are necessary for larval mosquito development [20]
but the mechanism of transmission of bacteria through
immature stages of development to the adult mosquito
midgut is controversial. Studies have shown that bacteria
provided to larvae can be identiﬁed in adult midguts [5, 8,
21] but other studies suggest that transstadial transmission
does not occur [22] and instead that MAB are derived from
adult sugar and water sources [23]. However, adaptation
of speciﬁc bacteria to eﬀective colonization of the midgut
is possible [24]. The interactions between mosquitoes and
bacteriathatleadtoeﬃcientcolonizationintheadultmidgut
must be understood for eﬀective introduction of inhibitory
MAB in wild mosquito populations in malaria endemic
areas.
Another important issue that must be resolved is the
concentration of MAB required for eﬃcient inhibition of
parasite development in the mosquito. As little as 100 bacte-
ria can signiﬁcantly impact P. falciparum development when
provided concurrently in a blood meal [1, 4]a n dM A Bc a n
inhibit oocyst formation when provided in sugar solution
prior to parasite challenge [4, 19], but the concentration
necessary for inhibition in natural settings is unknown.
3.TargetingHumanPlasmodium Parasites
UsingGeneticallyModiﬁedMosquitoes
Germline transformation of A. stephensi was ﬁrst reported in
2000 [25], and other important malaria vectors have since
been transformed [26, 27]. In the process of transformation,
a mobile genetic element is used to insert into the mosquito
genome a gene of interest that is under the control of a
speciﬁc promoter. Choice of promoters and eﬀector genes
are some of the most important factors for generating
mosquitoes that are refractory to Plasmodium infection and
in limiting the adverse ﬁtness eﬀects exerted by transgene
expression. Genetic drive systems to integrate the transgene
into wild mosquito populations are also essential for the
implementation of genetically modiﬁed mosquitoes as tools
for control of malaria transmission.
To target Plasmodium parasites during the developmen-
tal cycle, an eﬀective anti-Plasmodium transgene must be
expressed in a relevant tissue (midgut, fat body, and salivary
glands) at a relevant time (when the parasite is present in
that tissue). The promoter used for transgene expression
will determine the timing and the mosquito tissue in which
the transgene will be expressed. In anophelines, midgut-
speciﬁc transgene expression has been achieved using the
carboxypeptidase [28], peritrophin [29], Antryp1,a n dG12
[30] promoters, the vitellogenin promoter has been used to
drive transgene expression in the mosquito fat body [31],
and the apyrase [32]a n danopheline antiplatelet protein [33]
promoters can drive transgene expression in the salivary
glands. Conditional transgene expression in A. stephensi
midguts under the control of the SRPN10 promoter has also
been shown [34].
Expression of nonmosquito eﬀector molecules in trans-
genic mosquitoes has been used to decrease P. falciparum
development. Midgut-speciﬁc expression of a sea cucumber
C-type lectin in A. stephensi [35] and a synthetic anti-
Plasmodium peptide in A. gambiae [36] decreased oocyst
intensities. Transgenic technologies have also been used to
increase the expression of endogenous mosquito genes that
in turn increase anti-Plasmodium responses in the mosquito.
OverexpressionofAkt,akeysignalingmoleculeintheinsulin
signaling pathway, in the midguts of A. stephensi completely
blocks P. falciparum oocyst development [37]. Because the
Anopheles innate immune system is engaged at multipleJournal of Tropical Medicine 3
stages of Plasmodium infection and mediated through multi-
ple factors (reviewed in [38]), the transgenic overexpression
of multiple anti-Plasmodium immune eﬀectors in several
tissues at diﬀerent times during Plasmodium infection can
provide tiers of inhibition, targeting parasites that may have
escaped the ﬁrst lines of defense and decreasing the likeli-
hood of resistance developing in the parasite (Dimopoulos
et al. unpublished). Stable and heritable RNA interference-
mediated silencing of endogenous mosquito transcripts
through the expression of a hairpin-loop transgene [39]
might also be used to target negative regulators of anti-
Plasmodium responses to increase resistance to parasite
infection [18].
An eﬀective genetic drive mechanism is needed to
introduce anti-Plasmodium eﬀector transgenes into a wild
mosquito population. A drive mechanism should be pow-
e r f u le n o u g ht os p r e a dt h et r a n s g e n et on e a rﬁ x a t i o ni n
the population, be tightly linked with the transgene so
that separation cannot occur and have minimal impact on
mosquito ﬁtness. Potential drive mechanisms are naturally
occurring “selﬁsh” gene mechanisms with non-Mendelian
inheritance (reviewed in [40]) including, but not limited
to, transposable elements (TEs) homing endonuclease genes
(HEGs) and Medea.
TEs are mobile genetic elements that are capable of
moving rapidly into populations and can be engineered to
carry a transgene through a population. However, the rates
of transposition for the class II transposons Hermes, Minos,
Mos1,a n dpiggybac, which have been vital for mosquito
transgenesis, are not suﬃcient to serve as drive systems [41].
While TEs randomly integrate into a genome, HEGs use a
speciﬁc DNA sequence to integrate into the chromosome
through a mechanism of double-stranded DNA break repair.
These enzymes are active in A. gambiae cells and embryos
[42] and can also be engineered to carry speciﬁc DNA
sequences. A breakthrough in mosquito-based genetic drive
systems was recently achieved with the successful intro-
duction of an HEG into transgenic anopheline mosquitoes
[43]. In cage studies, it was shown that the genetic element
could invade na¨ ıve mosquito populations rapidly and may
provide a novel mechanism of genetic modiﬁcation of
wild mosquitoes [43]. Medea, or maternal-eﬀect-dominant
embryonic arrest, causes the death of all oﬀspring that do
notinherittheMedea-bearinggene[44].Inthissystem,there
is maternal expression of a toxin regulated by a germline-
speciﬁc promoter and only zygotes expressing an antidote
to the toxin will survive. Studies in the fruit ﬂy have shown
that Medea can eﬀectively and rapidly drive transgenes
into a population [44]. As novel mosquito germline-speciﬁc
promoters are discovered, such as DNA regulatory regions
of the vasa gene [45], both HEGs and Medea will have
tremendouspotentialasgeneticdrivesystemsinmosquitoes.
In order for transgenic mosquito technologies to be
successfully applied, the genetically modiﬁed mosquitoes
must be able to compete with wild mosquitoes. Therefore,
the transgenic mosquito must be reproductively ﬁt to ensure
that the transgene will ﬁx in the population. When a ﬁtness
cost is observed, it is diﬃcult to determine the origin [46].
The impact on mosquito ﬁtness could be due to insertional
mutagenesis caused by the integration of a transgene into an
endogenous gene [47, 48], the expression of the transgene
itself [29], or inbreeding repression due to rearing transgenic
mosquitoes to homozygosity [47]. However, some studies
show that transgenic mosquitoes are as ﬁt as nontransgenic
mosquitoes [49, 50]. Of note, a report by Marrelli et
al. [51] suggested that transgenic mosquitoes expressing
antimalarial eﬀectors may have a ﬁtness advantage over
wild-type mosquitoes when under the selective pressure of
continuous infection.
4. Comparison of Low- and High-Tech
Control Strategies
Here, we compare some of the important attributes for an
eﬀective control mechanism that each of these strategies has.
Mass Production. In order to test for anti-Plasmodium
activity in MAB, the microorganisms must ﬁrst be grown
in culture. Because of this, optimal bacterial candidates for
eventual release could be produced in mass quantities with
minimalsuppliesthatcouldbehousedin endemiccountries.
In contrast, mass production of mosquitoes requires large
facilities for rearing and sex selection and large amounts of
supplies.
StorageandTransportation. Bacteriacanbefreeze-dried[52]
for both storage and transportation, making introduction
intoremoteareaspossible.ThisalsosuggeststhatMABcould
be combined with current mosquito control strategies such
as entomopathogenic fungi in an applicable formulation
[53].Noprotocolsarecurrentlyavailableforthepreservation
of viable Anopheles eggs, making transportation of either
larvae or adult mosquitoes necessary.
Parasite Species Coverage and Selection Pressure. Mosquitoes
can develop resistance to the toxin of a current biocon-
trol bacterium (Bti) [54], but a bacterial product with
Plasmodium species speciﬁcity would be required for the
parasite to develop resistance. Population genetic studies
suggest that refractoriness is a dominant trait and that
Plasmodium infection is a result of immune failure [54–
56]. This, combined with a general antibacterial immune
response, suggests that the use of MAB to inhibit malaria
parasite infection of mosquitoes would not impart a selective
pressure on the parasite. Indeed, both P. falciparum and
P. vivax infections can be inhibited by MAB [1, 2, 4, 5].
For transgenic mosquitoes, the transgene will determine the
range of parasites that can be inhibited and the selective
pressureimpartedontheparasite.Currenteﬀectormolecules
may not impact human malaria parasites and transgenic
activation of mosquito anti-Plasmodium responses has only
been shown to inhibit P. falciparum [37]. The use of
transgenic mosquitoes expressing an exogenous gene may
be problematic in that the parasite could develop resistance,
but this would be overcome using endogenous immune gene
overexpression or multiple releases over time of mosquitoes
carrying diﬀerent transgenes.4 Journal of Tropical Medicine
Mosquito Species Coverage. The ability of a bacterium to
colonize or survive in the mosquito midgut is dependent on
the bacterium itself, whereas only mosquito species that have
been transformed or those that are capable of hybridization
with the transgenic species will be refractory to Plasmodium
infection.However,theintroductionofbacteriaisdependent
on the mosquito species found in the coverage area and the
route of introduction, whereas transgenic mosquitoes can
disperse and inﬁltrate the natural populations.
Oﬀ-Target Eﬀects. Release of bacteria into an ecosystem
could have eﬀects on other organisms. Depending on the
released bacterial species, there could be competition for
resources with other essential bacteria within the environ-
ment or unintended mortality in nontarget insects and
vertebrates. Assuming that the expressed transgene is not
released from the mosquito body, one would not expect oﬀ-
target eﬀects from the release of transgenic mosquitoes.
Time and Concentration Dependence. Bacteria can be eﬀec-
tive against Plasmodium in the midgut lumen and also
during oocyst maturation, but this time window requires
that bacteria be present prior to or soon after parasite
ingestion. Also, variation in the concentration of inhibitory
bacteria present in an individual mosquito can determine
the eﬃciency of inhibition [1, 4]. Therefore, there is a strict
correlation between the timing of bacterial introduction and
parasite inhibition. With transgenic mosquitoes, the timing
and level of transgene expression is controlled by a mosquito
promoter and is experimentally determined prior to release
of the mosquitoes into the ﬁeld.
Introduction into the Field. Bacterial formulations are cur-
rently used for biocontrol of mosquito larvae. However,
because of the unknown nature of the mosquito-bacteria
interaction and the carriage of bacteria through immature
stagestotheadultstage(discussedabove),thedetermination
of application procedures for eﬀective coverage of mosquito
populations remains to be resolved. Also, the number of
applications, bacterial concentration, and the size of cover-
age area are currently unknown. Transgenic Aedes aegypti
mosquitoes have recently been released in ﬁeld-based trials,
but this technology utilized a female killing-based technique
that reduces mosquito populations [57]. Mosquitoes with
an expressed transgene have not been released as of yet,
but could follow a similar strategy to that currently being
employed. Transgene integration into a population has been
shownexperimentallyinlarge-cagetrials[58]butnotinwild
mosquito populations.
Ethical Issues. Release of genetically modiﬁed organisms has
been under much scrutiny and a number of publications
address these issues [59–61]. Among these issues are ethical
concerns of education of potential risks in endemic coun-
tries, spread of the transgenic mosquito to other countries
that have not agreed to the release, and coverage under the
Cartagena Protocol [62]. Bacteria do not require genetic
modiﬁcation in order to exert an inhibitory eﬀect on
Plasmodium development in the mosquito and biocontrol
formulations using bacteria are currently in use, so ethical
issues of bacterial release may not be as great.
5. Conclusion
Even with tremendous research eﬀorts and ﬁnancial support
to control transmission, malaria remains the most impactful
vector-borne disease worldwide. As Plasmodium parasites
and the mosquito vectors continue to develop resistance to
eﬀective drugs and insecticides, we must continue the devel-
opment of novel strategies to interfere with the transmission
cycle. We have brieﬂy summarized two potential strategies
based on one “low-tech” approach using the mosquito’s
natural midgut microﬂora and one more technologically-
involved “high-tech” approach using transgenic mosquitoes
refractory to parasite infection. Each has their advantages
and disadvantages for eventual implementation, but in the
future may be combined as part of an integrated control
strategy for malaria transmission.
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